Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].

Simple item page
dc.contributor.authorReck, M
dc.contributor.authorCiuleanu, T-E
dc.contributor.authorCobo, M
dc.contributor.authorSchenker, M
dc.contributor.authorZurawski, B
dc.contributor.authorMenezes, J
dc.contributor.authorRichardet, E
dc.contributor.authorBennouna, J
dc.contributor.authorFelip, E
dc.contributor.authorJuan-Vidal, O
dc.contributor.authorAlexandru, A
dc.contributor.authorSakai, H
dc.contributor.authorLingua, A
dc.contributor.authorReyes, F
dc.contributor.authorSouquet, P-J
dc.contributor.authorDe Marchi, P
dc.contributor.authorMartin, C
dc.contributor.authorPérol, M
dc.contributor.authorScherpereel, A
dc.contributor.authorLu, S
dc.contributor.authorPaz-Ares, L
dc.contributor.authorCarbone, D P
dc.contributor.authorMemaj, A
dc.contributor.authorMarimuthu, S
dc.contributor.authorZhang, X
dc.contributor.authorTran, P
dc.contributor.authorJohn, T
dc.date.accessioned2025-01-07T12:24:08Z
dc.date.available2025-01-07T12:24:08Z
dc.date.issued2021-12-02
dc.identifier.doi10.1016/j.esmoop.2021.100345
dc.identifier.essn2059-7029
dc.identifier.pmcPMC8649668
dc.identifier.pmid34864501
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8649668/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.esmoop.2021.100345
dc.identifier.urihttps://hdl.handle.net/10668/24575
dc.issue.number6
dc.journal.titleESMO open
dc.journal.titleabbreviationESMO Open
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.number100345
dc.pubmedtypePublished Erratum
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCorrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number6

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8649668.pdf
Size:
216.22 KB
Format:
Adobe Portable Document Format
Download

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía